Device Trial Radar · NCT06107361
Evaluating the Role of the Guidewire in Peripheral Intravenous Access: A Randomized Controlled Trial of Ultrasound-Guided Catheter Survival
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
360
Actual
Start
Nov 7, 2023
Primary completion
Sep 30, 2026
Study completion Sep 30, 2026
Sponsor
- Lead sponsor
- Corewell Health EastAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 30, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, parallel, non-blinded, two-arm randomized controlled trial of intravenous catheter failure evaluating the impact of a built-in guide wire. The objective of this study is to demonstrate that the control ultralong intravenous catheter (IV) without the guide wire is non-inferior to the experimental catheter with the guide wire. After obtaining consent, eligible patients will be randomly allocated to control Arm 1 (ultralong intravenous catheter) or experimental Arm 2 (ultralong intravenous catheter with guide wire) in a ratio of 1:1 via a computer-generated randomization schedule. The participants will be followed to collect data until the catheter is removed.
Conditions
- Peripheral Intravenous Vein Catheter Phlebitis
- Intravenous Infection
Interventions
B. Braun 6.35cm 20 gauge ultralong intravenous catheterDevice
B Braun Medical Inc, 6.35cm 20 gauge ultralong intravenous catheter
BD 5.71 cm 20 gauge AccucathDevice
Bard Access Systems, Inc, BD 5.71 cm 20 gauge ultralong intravenous catheter with guide wire
Primary outcomes
What the sponsor says the trial is designed to measure.
- Survival of the BBraun 6.35 centimeter 20 gauge ultralong intravenous catheter compared to the BD 5.71 cm 20 gauge ultralong intravenous catheter with guide wireTime frame: up to 15 days or the duration of the IV catheter
- Time to insertionTime frame: First day of hospitalization
- First-stick success rateTime frame: First day of hospitalization
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Beaumont Hospital - Royal Oak
Royal Oak, Michigan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.